September 18, 2014 11:28 PM ET

Healthcare Equipment and Supplies

Company Overview of Tandem Diabetes Care, Inc.

Company Overview

Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company’s products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabe...

11045 Roselle Street

San Diego, CA 92121

United States

Founded in 2006

324 Employees

Phone:

858-366-6900

Key Executives for Tandem Diabetes Care, Inc.

Chief Executive Officer
Age: 62
Total Annual Compensation: $472.1K
Chief Financial Officer and Principal Accounting Officer
Age: 48
Total Annual Compensation: $362.6K
Chief Commercial Officer and Executive Vice President
Age: 63
Total Annual Compensation: $265.0K
Chief Administrative Officer
Age: 35
Total Annual Compensation: $275.2K
Compensation as of Fiscal Year 2013.

Tandem Diabetes Care, Inc. Key Developments

Tandem Diabetes Care Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Year Ending December 31, 2014

Tandem Diabetes Care Inc. announced unaudited earnings results for the second quarter and six months ended June 30, 2014. For the second quarter, the company reported sales of $10,255,000 compared with $5,528,000 for the same period in the last year. Operating loss was $18,318,000 compared with $13.677.000 for the same period in the last year. Net loss was $19,197,000 compared with $15,301,000 for the same period in the last year. Net loss per share basic and diluted were $0.83 compared with $72.50 for the same period in the last year. For the six months, the company reported sales of $18,320,000 compared with $10,986,000 for the same period in the last year. Operating loss was $39,156,000 compared with $20,843,000 for the same period in the last year. Net loss was $41,159,000 compared with $26,464,000 for the same period in the last year. Net loss per share basic and diluted were $1.79 compared with $75.42 for the same period in the last year. For the year ending December 31, 2014, the company's expects sales to be in the range of $48.0 million to $54.0 million and operating margin is estimated to be in the range of negative 130% to 140%, which includes approximately $15.0 million to $16.0 million in non-cash, stock-based compensation expense.

Tandem Diabetes Care, Inc. to Report Q2, 2014 Results on Jul 31, 2014

Tandem Diabetes Care, Inc. announced that they will report Q2, 2014 results After-Market on Jul 31, 2014

Tandem Diabetes Care, Inc., Q2 2014 Earnings Call, Jul 31, 2014

Tandem Diabetes Care, Inc., Q2 2014 Earnings Call, Jul 31, 2014

Similar Private Companies By Industry

Company Name Region
NeuroSigma, Inc. United States
KayPENTAX Inc. United States
Vascular Pathways, Inc. United States
Neurognostics, Inc. United States
Cardiac Advancements, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tandem Diabetes Care, Inc., please visit www.tandemdiabetes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.